The Division of Molecular & Clinical Medicine within the School of Medicine at the University of Dundee focuses on the pathogenesis and the treatment of cardiovascular disease, diabetes mellitus, respiratory medicine and ageing and health.
The research aims of the Division are to maintain and increase excellence in:
The population bioresources and genomics theme of CVDM investigates the genetic basis for susceptibility to, and treatment of diabetes and cardiovascular diseases. This grouping has pioneered the linkage of genomics to the electronic medical record.
Research in these theme spans from clinical endocrinology focusing on thyroid, pituitary and adrenal disease, through reproductive endocrinology to Neuroendocrinology.
Researchers in this theme study the epidemiology, pathophysiology and pharmacology of asthma, chronic obstructive pulmonary disease (COPD), lung inflammation, respiratory infections, rare inherited rare diseases (eg. Cystic Fibrosis, Birt-Hogg-Dubé syndrome) and fetal origins of cardio-pulmonary disease.
The focus of this theme is the organ specific consequences of metabolic stress from diet, life style and the environment. Projects truly go from bench-to-bedside, bedside-to-bench and clinic to community, with the over-arching goal being to aim to improve the health of individuals and the community.
Clinical trials of different sizes are undertaken to assess the effectiveness of new biomarkers and new therapies in Cardiovascular Medicine, in Diabetes Medicine, in Respiratory Medicine and in Ageing & Health. They range in size from “proof of concept” small studies to large multicentre trials